Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro.
Where this comes from
- Record sourced from PubMed, PMID 19579295.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Some time has passed since the torrent of discussion surrounding the cardiovascular risk of pushing up hemoglobin concentrations in dialysis patients with erythropoietin. The debate here reflects a look back on the tension produced by confusing data and outcomes. Is it the target hemoglobin per se or the high doses of erythropoietin in subsets of resistant patients that is the problem? You decide.
Medical subject headings
- Anemia
- Cardiovascular Diseases
- Erythropoietin
- Hemoglobins
- Kidney Diseases